Allergan Aesthetics reports positive CHMP opinion recommending approval of Boey (trenibotulinumtoxinE)

Sobi reports positive topline results from Phase 3 study of pozdeutinurad in gout

Bayer's KERENDIA receives FDA priority review for type 1 diabetes and kidney disease treatment

Circio files new patent application for circVec gene therapy platform

BioMarin Pharmaceutical meets primary endpoint in Phase 3 study of VOXZOGO in children with hypochondroplasia

Hyundai Bioscience says XAFTY available for Ebola and Hantavirus treatment

4basebio secures clinical supply agreement for Phase II immunotherapy trial

FDA approves MEKanistic Therapeutics' IND for MTX-531

Sino Biological launches XPressMAX Cell-Free Protein Synthesis Kit

Matter Bio submits first IND application for Lm-LLO-TT

Myosin Therapeutics doses first patient in Phase 1/2 study of MT-125 in GBM

Nanjing Leads Biolabs receives Chinese approval for pivotal Phase III trial of PD-L1/4-1BB bispecific antibody

Accro Bioscience completes USD50m Series C financing

AstraZeneca wins US approval for Baxfendy as first aldosterone synthase inhibitor for hypertension

GSK's Arexvy gains expanded approval in Japan for at-risk adults aged 18-49